CRISPR screening uncovers a long-range enhancer for ONECUT1 in pancreatic differentiation and links a diabetes risk variant
Cell Reports · 2024
DOI: 10.1016/j.celrep.2024.114640 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Samuel Joseph Kaplan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Weill Cornell Graduate School of Medical Sciences, Weill Cornell Medical College, New York, NY 10065, USA; Developmental Biology Program, Sloan Kette…. Hauptthemen laut MEDLINE: Enhancer Elements, Genetic, Cell Differentiation, Pancreas. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHGRI NIH HHS, NCI NIH HHS, NIGMS NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Weill Cornell Graduate School of Medical Sciences, Weill Cornell Medical College, New York, NY 10065, USA; Developmental Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 1…
- Weill Cornell Graduate School of Medical Sciences, Weill Cornell Medical College, New York, NY 10065, USA; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, Ne…
- Developmental Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Ce…
- Developmental Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
- Weill Cornell Graduate School of Medical Sciences, Weill Cornell Medical College, New York, NY 10065, USA.
- Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Förderung
- NHGRI NIH HHS
- NCI NIH HHS
- NIGMS NIH HHS
- NIDDK NIH HHS
- National Cancer Institute
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Human Genome Research Institute
Zitieren
APA
Kaplan, S. J., Wong, W., Yan, J., Pulecio, J., Cho, H. S., Li, Q., Zhao, J., Leslie-Iyer, J., Kazakov, J., Murphy, D., Luo, R., Dey, K. K., Apostolou, E., Leslie, C. S., & Huangfu, D. (2024). CRISPR screening uncovers a long-range enhancer for ONECUT1 in pancreatic differentiation and links a diabetes risk variant. Cell Reports. https://doi.org/10.1016/j.celrep.2024.114640
Vancouver
Kaplan SJ, Wong W, Yan J, Pulecio J, Cho HS, Li Q, et al. CRISPR screening uncovers a long-range enhancer for ONECUT1 in pancreatic differentiation and links a diabetes risk variant. Cell Reports. 2024. doi:10.1016/j.celrep.2024.114640
BibTeX
@article{Kaplan2024,
author = {Kaplan, Samuel Joseph and Wong, Wilfred and Yan, Jielin and Pulecio, Julian and Cho, Hyein S and Li, Qianzi and Zhao, Jiahui and Leslie-Iyer, Jayanti and Kazakov, Jonathan and Murphy, Dylan and Luo, Renhe and Dey, Kushal K and Apostolou, Effie and Leslie, Christina S and Huangfu, Danwei},
title = {CRISPR screening uncovers a long-range enhancer for ONECUT1 in pancreatic differentiation and links a diabetes risk variant},
journal = {Cell Reports},
year = {2024},
doi = {10.1016/j.celrep.2024.114640}
}
EUVIMED